Castillo, Angelie T.
HRN: 05-00-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/31/2024
02/01/2024
IV
900mg
Q8hours
S/P LTCS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes